Pirfenax (Pirfenax)200 MG – 30 tablet

$28.82

Each Pirfenax contains 200 mg Pirfenidone 30 tablets used to treat idiopathic pulmonary fibrosis, a progressive lung disease.

ATC Classification: L04AX05
Active Ingrediant: Pirfenidone
Generic Name: Pirfenax
Manufacturer: Cipla Limited
Strength: 200 MG
Dosage Type: Tablet CR
Packaging Type: Foil in Box
Contains: 30 Tabs

Important update for customers in the USA:

Most of the World has stopped all packages mailing to the USA due to De Minimus Exemption.

  1. WE ARE SHIPPING TO THE USA The only or best option right now is trans shipment to the USA, we are holding India post and express mail shipments until India sets up a taxation / tariff collection system on our side which they say can take 1 month or longer.
  2. We ship normally to the UK, AUS, Japan, and most others. The situation only involves the USA.
  3. For people who have placed an order for express mail we will ship this out once India mail is open or you can contact us to make arrangements to ship through Trans Shipping and pay the tariff and shipping costs this way.
  4. We are very sorry for this, the USA policy shift came fast, without rules or regulations, and not understanding of what other countries should do.
  5. As things develop we will adjust our shipping prices and operations to best service you.
Thanks for your patience.
Pirfenax (Pirfenax)200 MG – 30 tablet
Pirfenax (Pirfenax)200 MG – 30 tablet
$28.82

 

Storage/Stability

Store at 25°C (77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F).

 

Adverse Reactions

>10%:

Central nervous system: Fatigue (26%), headache (22%), dizziness (18%)

Dermatologic: Skin rash (30%)

Gastrointestinal: Nausea (36%), diarrhea (26%), abdominal pain (24%), dyspepsia (19%), anorexia (13%), vomiting (13%), gastroesophageal reflux disease (11%)

Respiratory: Upper respiratory tract infection (27%), sinusitis (11%)

1% to 10%:

Central nervous system: Insomnia (10%), noncardiac chest pain (5%)

Dermatologic: Skin photosensitivity (9%), pruritus (8%)

Endocrine & metabolic: Weight loss (10%)

Gastrointestinal: Decreased appetite (8%), dysgeusia (6%)

Hepatic: Increased serum transaminases (ALT and AST; ≥3 x ULN: 4%)

Neuromuscular & skeletal: Arthralgia (10%), asthenia (6%)

Postmarketing: Agranulocytosis, angioedema, hepatotoxicity

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , ,

Strength

Dosage Type

Packaging Type

Brand

Cipla

Reviews

There are no reviews yet.

Be the first to review “Pirfenax (Pirfenax)200 MG – 30 tablet”

Your email address will not be published. Required fields are marked *